applying our ED protocol to different number of subunits (SUs). Our simulations showed that the movement of a single SU is not sufficient to open the activation gate. But by moving three SUs by ED simulations, the activation gate opened to the same extent as in the four SUs ED simulation protocol. These finding is in line with fluorescence detection studies, which showed that the SUs act cooperatively during gating (Blunck et al. 2008). Department of Pharmacological and Physiological Sciences, Saint Louis University, Saint Louis, MO, USA. KirBac1.1 is a bacterial inward rectifier potassium (Kir) channel, which, contrary to its eukaryotic homologues, is strongly inhibited by phosphatidylinositol-4,5-bisphosphate (PIP2). The most recent crystal structures of eukaryotic Kir2.2 in complex with PIP2 indicate that the TM-CD linker forms a short a-helix in the presence of PIP2. As a result, the cytoplasmic domain of Kir2.2 moves about 6 angstrom towards the membrane surface. However, the 'KKR' motif in the TM-CD linker of Kir2.2, which directly interacts with PIP2, is absent in KirBac1.1 and the question arises: how does KirBac1.1 cytoplasmic domain move in response to PIP2 inhibition? In the present work, we have made KirBac1.1 tandem tetramer constructs and purified KirBac1.1 tandem proteins successfully. Reconstituted liposome flux assays indicate that the KirBac1.1 tandem protein remains functional, and retains sensitivity to PIP2 inhibition. We introduced two cysteine into the KirBac1.1 tandem tetramer, one at the extracellular loop of subunit 1 (G85 or T120) and one in the cytoplasmic domain of subunit 2 (A273). We labeled these cysteines with a FRET dye pair (Alexa-Fluor 488 and DABCYL) and measured FRET efficiencies in protein samples reconstituted into liposomes, in the absence and presence of PIP2. Our results indicate that the KirBac1.1 cytoplasmic domain moves~2-3 angstrom away from the transmembrane domain in the presence of PIP2 -opposite the direction suggested from eukaryotic Kir2.2 crystal structures in the presence and absence of PIP2. Reversed PIP2-dependent motions of the cytoplasmic domain with respect to the transmembrane domain between prokaryotic and eukaryotic Kir channels may explain their differential response to PIP2 modulation.
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Simulations of the Helix Bundle Crossing Gate Opening in Kir Channels Xuanyu Meng, Meng Cui, Diomedes E. Logothetis. Virginia Commonwealth University, Richmond, VA, USA. Inwardly rectifying K þ (Kir) channels are gated by the phospholipid PIP 2 . Along the ion permeation pathway, three relatively narrow regions (the selectivity filter -SF, the inner helix bundle crossing (HBC), and the intracellular G-loop) may serve as gates to control ion permeation. A crystal structure of a Kir3.1 chimera [Nishida et al., 2007] captured the cytosolic G-loop gate in ''closed/constricted'' or ''open/dilated'' conformations. 100 ns Molecular Dynamics (MD) simulations studying the PIP 2 -driven Kir channel activation of the Kir3.1 chimera led us to propose a molecular mechanism of the G-loop gate opening [Meng et al., 2012] . However, opening of the HBC gate was not observed throughout this simulation. Mutagenesis and single-channel recording studies in our lab showed that a proline mutation on the inner helix of the Kir3.4 channel dramatically increased the open probability of the channel [Jin et al., 2002] . We introduced the corresponding M170P mutation on the Kir3.1 chimera structure and ran 100 ns long simulations of four mutant channel systems: dilated and constricted M170P Kir3.1 chimera in the presence (holo) and absence (apo) of PIP 2 , using the GROMACS program [Hess et al., 2008] . Three potassium ions present in the SF passed through the HBC gate in the system of the holo dilated M170P Kir3.1 chimera within the 100 ns simulation time. Minimal distance measurements indicated that the HBC gate was able to open only when PIP 2 was present and the G-loop gate was stabilized in the open state. Principal component analysis revealed coupled conformational changes in the Slide helix, DE-and LM-loops, possibly related to the opening of the HBC gate. Moreover, unique residue interactions within the transmembrane domains were observed in the dilated holo system. Predictions of these models are being tested experimentally. Background: Inward rectifier potassium channels play a key role in setting and maintaining the resting membrane potential and regulating excitability in various tissues. Kir2.x subfamily members mediate the cardiac inward rectifier potassium current (IK1). KCNJ2 encodes Kir2.1, the pore-forming alpha subunit responsible for cardiac IK1, and the mutations in this gene are associated with type 1 Andersen-Tawil Syndrome (ATS1). A Kir2.1 missense mutation, M307I, has been identified in a Korean family with ATS1. We found that the ATS1-associated M307I mutation is a loss-of-function mutation in KCNJ2 that mediates a dominant-negative effect on wild-type (WT) channels. M307I is located in the intracellular C-terminal domain in a region known to be associated with putative phosphatidylinositol 4,5-bisphosphate (PIP2) binding and channel trafficking. Here we explored the mechanisms underlying the dominant-negative effect of the mutation. Methods and Results: Human Kir2.1 was subcloned into pFlag-CMV vector and pFlag-Kir2.1-M307I was generated by site-direct mutagenesis. The FlagKir2.1-WT and Flag-Kir2.1-M307I were expressed in HEK293 cells and affinity purified. PIP2-binding was assessed using a Lipid-bead-protein pull-down assay with cell lysate and Protein-lipid overlay assay with purified proteins. The electrophysiological data showed that the M307I mutant channel significantly reduces whole cell current densities when co-expressed with Kir2.1-WT channels. Immunofluorescence (IF) staining assays reveal that M307I channels exhibit normal membrane trafficking. PIP2 binding assays show that Flag-Kir2.1-M307I channels exhibit dramatically decreased binding to PIP2 compared to WT channels. Conclusions: M307I is an ATS1-associated, loss-of-function missense mutation in KCNJ2 that mediates a dominant-negative effect on WT channels by reducing PIP2 binding to the channel. þ channels contributes to an increased risk of cardiac arrhythmia in heart failure and to impaired cerebral arterial dilation in chronic alcohol consumption. The downregulation mechanism is unknown, although post-transcriptional regulation of gene expression by microRNAs is a strong possibility that has not been fully investigated. miR-212 is markedly augmented in heart failure and in chronic alcoholism, and is predicted by bioinformatic algorithms to target K ir 2.1, the predominant inward rectifier K þ channel expressed in heart and arterial smooth muscle. We developed a fluorescence-based assay for identifying microRNA targets, using mCherry red Sunday, February 3, 2013 129a 
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